MedTrace Logo

Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment

NCT06897969 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-04-01

No results posted yet for this study

Summary

This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.

Conditions

  • Keloid Scars

Interventions

DRUG

Triamcinolone Acetonide 1 ml of 40 mg/mL suspension

Monthly intralesional injection

DRUG

Verapamil Injection

2.5 mg of intralesional Verapamil injection monthly

Sponsors & Collaborators

  • Nishtar Medical University

    lead OTHER

Principal Investigators

  • Dr. Aliya Akhtar, FCPS · Nishtar Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06897969 on ClinicalTrials.gov